These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Animal experiments on the safety pharmacology of lofexidine. Graf E, Sieck A, Wenzl H, Winkelmann J. Arzneimittelforschung; 1982; 32(8a):931-40. PubMed ID: 6890367 [Abstract] [Full Text] [Related]
5. Double-blind comparison of the hypotensive, sedative and salivary flow effects of lofexidine and clonidine in normal subjects. Dollery CT, Reid JL. Arzneimittelforschung; 1982; 32(8a):984-7. PubMed ID: 6890374 [Abstract] [Full Text] [Related]
16. Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. III. Action on the secretions of the digestive tract and on the central nervous system, acute toxicity. Cosnier D, Hache J, Labrid C, Streichenberger G. Arzneimittelforschung; 1975 Jan; 25(12):1926-33. PubMed ID: 3186 [Abstract] [Full Text] [Related]
18. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats. Buccafusco JJ, Lapp CA, Westbrooks KL, Ernsberger P. J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087 [Abstract] [Full Text] [Related]